祥生医疗：关于向2025年限制性股票激励计划激励对象授予限制性股票的公告

Core Points - The company announced the approval of a restricted stock incentive plan for 17 individuals, with a grant date set for October 23, 2025 [2] - The grant price for the restricted stock is determined at 16.50 yuan per share, totaling 160,000 shares to be awarded [2] Company Actions - The company held its 16th meeting of the third board of directors and the 6th meeting of the remuneration and assessment committee on October 23, 2025 [2] - The decision to grant restricted stock is part of the company's strategy to incentivize key personnel [2]